Gland Pharma IPO is said to be the largest Pharma IPO in India. Isn’t that exciting? Hyderabad based Gland Pharma company is about to launch its IPO from 9th November 2020 to 11th November 2020. The Gland Pharma IPO size is said to be about Rs. 6480 Crores. The Grand Pharma IPO Grey Market Premium is surging, so do apply for this IPO.
Gland Pharma is one of the fastest-growing generic injectables-focused companies. Gland Pharma has seven manufacturing facilities in India, which includes four finished formulations facilities with a total of 22 production lines and three API facilities.
Also Read : Gland Pharma IPO Review
Gland Pharma IPO Subscription Status Live
Last Data Updated on 11th November 2020,6:00 PM
(Refresh The Page)
Category | Day 1 | Day 2 | Day 3 |
QIB | 0.00 | 0.48 | 6.40 |
NII | 0.01 | 0.03 | 0.51 |
Retail | 0.08 | 0.15 | 0.24 |
Total | 0.04 | 0.22 | 2.06 |
Brokerage Firm Gland Pharma IPO Reviews:
- Axis Capital – None
- Capital Market – Other
- Dilip Davda – Other
- GEPL Capital Ltd – Subscribe
- ICICI Direct – Subscribe
- Kotak Securities – Other
- S P Tulsian – Subscribe
Gland Pharma IPO Dates & Price Band :
IPO Open: | 09 November 2020 |
IPO Close: | 11 November 2020 |
IPO Size: | Approx ₹6480 Crore |
Price Band: | ₹1490 – ₹1500 Per Share |
Listing on: | BSE & NSE |
Retail Portion: | 35% |
Equity: | 43,196,968 Shares |
Gland Pharma IPO Market Lot:
- Shares: Minimum 10 Shares & Maximum 130 Shares
- Minimum Amount: ₹15,000
Gland Pharma IPO Allotment & Listing:
- Basis of Allotment: 17 November 2020
- Refunds: 18 November 2020
- Credit to Demat accounts: 19 November 2020
- Listing: 20 November 2020
Read Also
Gland Pharma IPO Date and Review
Gland Pharma IPO Grey Market Premium
Gland Pharma IPO Allotment Status
Gland Pharma IPO Listing Date